RESEARCH USE ONLY | Free Shipping Over £140

High Purity

Laboratory Tested

Secure Payments

Bank Transfer & More

Delivery

UK & Europe Wide

B7-33 2mg

B7-33 2mg

£21.95

B7-33 is a novel relaxin analogue extensively studied for its anti-fibrotic and anti-inflammatory properties. Research indicates potential benefits in cardiovascular and fibrotic diseases, with ongoing investigations exploring its applications in cardiology, nephrology, and hepatology.

Category

Secure Payment

High Purity

Fast Delivery

  • Description
  • Additional Information
B7-33 is a novel peptide analogue of the hormone relaxin that has been the subject of intensive scientific research, particularly in the fields of cardiovascular and fibrotic diseases. Studies have demonstrated its ability to activate the relaxin receptor RXFP1, mimicking many of the beneficial effects of native relaxin. In vitro and animal model investigations have shown B7-33's capacity to reduce fibrosis and inflammation in various tissues. Preclinical research has explored its potential cardioprotective properties, with data suggesting improvements in heart function and reduced cardiac fibrosis. Investigators have also examined its effects on kidney function, with studies indicating possible benefits in models of chronic kidney disease. Additionally, research has investigated B7-33's potential in treating pulmonary fibrosis and liver fibrosis. The peptide's unique pharmacokinetic profile, including enhanced stability and bioavailability compared to native relaxin, has made it a promising candidate for clinical development. While human trials are still in early stages, B7-33 continues to be a subject of intense scientific inquiry for its potential therapeutic applications in fibrotic and cardiovascular disorders.